Flagship Biosciences Applauded by Frost Sullivan for Changing Biomarker Analysis to Find Biomarkers that Aid Drug Development and Diagnostics
- Written by PR Newswire
![]() |
Digital pathology solutions are increasingly used in the preclinical and clinical development phases, particularly toxicologic pathology and clinical trials, speeding up the process and curtailing expenses.
SAN ANTONIO, Feb. 15, 2023 /PRNewswire/ -- Frost & Sullivan assessed the artificial intelligence (AI)-enabled digital pathology solutions...